Please provide your email address to receive an email when new articles are posted on . Corneal cross-linking should be considered as a viable treatment for patients of all ages with keratoconus due ...

There is no cure for keratoconus, but the cornea can be strengthened to slow or halt the progression of the disease with an FDA-approved cross-linking procedure called iLink®. Once diagnosed, there is ...

Keratoconus is a progressive eye condition that affects the shape and clarity of the cornea, often beginning in the teenage ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Welcome to another edition of ...

Credit: Glaukos. Epioxa does not require the removal of the corneal epithelium, a step usually required by traditional corneal cross-linking procedures, thereby minimizing pain and recovery time.

A progressive eye condition, Keratoconus, is increasingly affecting young adults due to digital lifestyles. This disorder thins and bulges the cornea, causing blurred vision. Early detection through ...

SHREVEPORT, La. - Many people suffer with vision problems for years without knowing their blurred vision, glare or halos are due to a condition called keratoconus. WK Eye Institute is now offering a ...

Prior to the mainstream introduction of corneal collagen cross-linking (CXL) in the late 2000s, there was no effective treatment to prevent progression of keratoconus, other than corneal grafting ...

SHERBORN, Mass.--(BUSINESS WIRE)--CXL Ophthalmics, Inc., a clinical-stage company developing a minimally-invasive treatment for keratoconus, today published results of the EpiSmart cross-linking Phase ...

"A new vision for keratoconus: Epioxa redefines treatment after a decade-long wait" was originally created and published by ...

Providence Health Plan, Health New England, and Public Employees Health Plan Are Latest to Join Extensive List of Payers Covering Over 95% of Estimated Total U.S. Addressable Market for Progressive ...

WALTHAM, Mass.--(BUSINESS WIRE)--Avedro, Inc., an ophthalmic pharmaceutical and medical device company and world leader in corneal remodeling, today announced that 50 commercial insurance plans now ...